Abstract LB-123: Analysis of cell-free plasma DNA (cfDNA) identifies 3 molecular subtypes of acquired resistance to AZD9291, a novel EGFR tyrosine kinase inhibitor (TKI), in patients (pts) with advanced lung cancer

Kinase Inhibitor ◽

Molecular Subtypes ◽

Acquired Resistance ◽

Advanced Lung Cancer ◽

Plasma Dna ◽

Free Plasma

Spatiotemporal T790M heterogeneity in individual patients with non-small cell lung cancer (NSCLC) after acquired resistance to EGFR-tyrosine kinase inhibitor (TKI).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.8067 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 8067-8067 ◽

Cited By ~ 1

Author(s):

Akito Hata ◽

Nobuyuki Katakami ◽

Hiroshige Yoshioka ◽

Katsuhiro Masago ◽

Shiro Fujita ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor

New insights into acquired resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor therapy in lung cancer

Annals of Oncology ◽

10.1093/annonc/mdz063.030 ◽

2019 ◽

Vol 30 ◽

pp. ii51

Author(s):

J. Fassunke ◽

C. Heydt ◽

S. Michels ◽

B. Van Veggel ◽

F. Müller ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Resistance Mechanisms ◽

Third Generation ◽

Egfr Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor Therapy

Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer

BMC Cancer ◽

10.1186/1471-2407-13-606 ◽

2013 ◽

Vol 13 (1) ◽

Cited By ~ 43

Author(s):

Wonjun Ji ◽

Chang-Min Choi ◽

Jin Kyung Rho ◽

Se Jin Jang ◽

Young Soo Park ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Korean Patients ◽

Egfr Tyrosine Kinase

Mutation abundance affects the efficacy of EGFR tyrosine kinase inhibitor readministration in non-small-cell lung cancer with acquired resistance

Medical Oncology ◽

10.1007/s12032-013-0810-6 ◽

2013 ◽

Vol 31 (1) ◽

Cited By ~ 9

Author(s):

Ze-Rui Zhao ◽

Jin-Feng Wang ◽

Yong-Bin Lin ◽

Fang Wang ◽

Sha Fu ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitor

Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatment

Translational Lung Cancer Research ◽

10.21037/tlcr-21-691 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Soohyun Hwang ◽

Tae Hee Hong ◽

Sehhoon Park ◽

Hyun-Ae Jung ◽

Jong-Mu Sun ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Kinase Inhibitor ◽

Molecular Subtypes ◽

Small Cell ◽

Small Cell Lung ◽

Inhibitor Treatment

757 Loss of IGF-binding Protein 3 of EGFR Mutant Lung Cancer Cells in Acquired Resistance to EGFR-tyrosine Kinase Inhibitor

European Journal of Cancer ◽

10.1016/s0959-8049(12)71393-x ◽

2012 ◽

Vol 48 ◽

pp. S179

Author(s):

C.M. Choi ◽

H.Y. Kim ◽

Y.S. Park ◽

J.C. Lee

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Cancer Cells ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Igf Binding ◽

Egfr Mutant ◽

Igf Binding Protein

Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI

Case Medical Research ◽

10.31525/ct1-nct04007835 ◽

2019 ◽

Author(s):

Keyword(s):

Tyrosine Kinase ◽

Advanced Nsclc ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Egfr Tyrosine Kinase ◽

Nsclc Patients ◽

Egfr Tki

Egfr-Tyrosine Kinase Inhibitor (Tki) Rechallenge with Bevacizumab in Egfr-Mutant Non-Small Cell Lung Cancer (Nsclc)

Annals of Oncology ◽

10.1093/annonc/mdu349.65 ◽

2014 ◽

Vol 25 ◽

pp. iv452

Author(s):

K. Otsuka ◽

A. Hata ◽

R. Kato ◽

J. Takeshita ◽

C. Okuda ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Mutant

EGFR tyrosine kinase inhibitor therapy for lung cancer treatments and their clinical outcomes: A cohort study in Taiwan

Oncology Letters ◽

10.3892/ol.2019.10942 ◽

2019 ◽

Author(s):

Ching‑Hu Chung

Keyword(s):

Lung Cancer ◽

Cohort Study ◽

Tyrosine Kinase ◽

Clinical Outcomes ◽

Kinase Inhibitor ◽

Cancer Treatments ◽

Egfr Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor Therapy

EGFR mutation testing in blood for guiding EGFR tyrosine kinase inhibitor treatment in patients with nonsmall cell lung cancer

Medicine ◽

10.1097/md.0000000000006151 ◽

2017 ◽

Vol 96 (7) ◽

pp. e6151 ◽

Cited By ~ 1

Author(s):

Jin-Qiu Yuan ◽

Yue-Lun Zhang ◽

Hai-Tao Li ◽

Chen Mao

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Nonsmall Cell Lung Cancer ◽

Inhibitor Treatment ◽

Egfr Mutation Testing